Futura Medical Plc releases results from phase 3 study

  • Dec 10, 2019 GMT
  • Team Kalkine
  • The study investigated the efficiency and safety of 0.2%, 0.4% and 0.6% glyceryl trinitrate doses on patients
  • All three primary co-primary endpoints (IIEF-EF, SEP2 and SEP3) were achieved against baseline data
  • Safety and tolerability were also highly encouraging
  • On 10th December 2019, the stock of FUM was trading at GBX 12.62 at GMT 08:37 AM, down 16.38 points or 56.47% from its previous close.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK